Bone grafts: which is the ideal biomaterial?

HJ Haugen, SP Lyngstadaas, F Rossi… - Journal of clinical …, 2019 - Wiley Online Library
Bovine xenograft materials, followed by synthetic biomaterials, which unfortunately still lack
documented predictability and clinical performance, dominate the market for the cranio …

UK guidelines for the management of soft tissue sarcomas

A Dangoor, B Seddon, C Gerrand, R Grimer… - Clinical sarcoma …, 2016 - Springer
Soft tissue sarcomas (STS) are rare tumours arising in mesenchymal tissues, and can occur
almost anywhere in the body. Their rarity, and the heterogeneity of subtype and location …

[HTML][HTML] Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

A Gronchi, AB Miah, AP Dei Tos, N Abecassis… - Annals of …, 2021 - Elsevier
Highlights•This Clinical Practice Guideline provides key recommendations on the
management of soft tissue and visceral sarcomas.•Recommendations have been agreed …

[HTML][HTML] Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack… - Annals of …, 2018 - Elsevier
Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular
subsets, characterised by a low to very low incidence in all populations. The majority of …

[HTML][HTML] Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO/European Sarcoma Network Working Group - Annals of Oncology, 2014 - Elsevier
Extraskeletal Ewing sarcoma is covered by other ESMO Guidelines: in general, the same
principles for these tumours in children apply to adults. This is also the case for embryonal …

UK guidelines for the management of soft tissue sarcomas

AJ Hayes, IF Nixon, DC Strauss, BM Seddon… - British Journal of …, 2024 - nature.com
Soft tissue sarcomas (STS) are rare tumours arising in mesenchymal tissues and can occur
almost anywhere in the body. Their rarity, and the heterogeneity of subtype and location …

Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells

PH Goff, L Riolobos, BJ LaFleur… - Clinical Cancer …, 2022 - aacrjournals.org
Purpose: To characterize changes in the soft-tissue sarcoma (STS) tumor immune
microenvironment induced by standard neoadjuvant therapy with the goal of informing …

Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy

NS Ezuddin, J Pretell-Mazzini, RL Yechieli, DA Kerr… - Skeletal radiology, 2018 - Springer
Soft-tissue sarcomas pose diagnostic and therapeutic challenges to physicians, owing to the
large number of subtypes, aggressive tumor biology, lack of consensus on management …

Opportunities and challenges in soft tissue sarcoma risk stratification in the era of personalised medicine

A Chowdhury, K Thway, S Pasquali… - … Treatment Options in …, 2024 - Springer
Opinion Statement Soft tissue sarcomas (STS) are a rare and heterogeneous group of
cancers. Treatment options have changed little in the past thirty years, and the role of …

Does a less intensive surveillance protocol affect the survival of patients after treatment of a sarcoma of the limb?: updated results of the randomized TOSS study

A Puri, P Ranganathan, A Gulia, S Crasto… - The bone & joint …, 2018 - boneandjoint.org.uk
Aims A single-centre prospective randomized trial was conducted to investigate whether a
less intensive follow-up protocol would not be inferior to a conventional follow-up protocol, in …